All posts by: Michael Zand

About Michael Zand

Crowdfunding may ‘mislead’ on stem cell treatments – BioNews

Continue reading

2018-05-21 NEWS

Crowdfunding may ‘mislead’ on stem cell treatments
BioNews
Crowdfunding campaigns to raise money for stem cell treatments tend to exaggerate potential benefits while understating potential risks of the interventions, suggests a new study. When insurance companies will not pay for unproven stem cell treatments, …

Continue reading

2018-05-21 NEWS

Profit Confidential

CRSP Stock Is Leading With This Revolutionary Technology
Profit Confidential
Scientists, however, have made a breakthrough that exploits the human body’s natural defense mechanism that protects bacteria against viral infections. A handful of companies are working on this technology, and CRISPR Therapeutics AG (NASDAQ:CRSP) …
Brokers Watch List: CRISPR Therapeutics AG (NASDAQ:CRSP) vs CenterPoint Energy, Inc. (NYSE:CNP)TopChronicle
The Top Three Holders Of CRISPR Therapeutics AG (CRSP)Post Analyst
CRISPR Therapeutics (CRSP) Earns Daily Media Sentiment Score of 0.28The Ledger Gazette
Alpha Beta Stock –StockNewsGazette –Week Herald
all 55 news articles »